A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found. Drugs for type 2 diabetes commonly target insulin, which lowers blood glucose levels…

LONDON (Reuters) – Health data released on Wednesday provided the clearest evidence to date of the spread of chronic diseases like diabetes and heart disease from developed nations to poorer regions such as Africa, as lifestyles and diets there change. The United Nations data showed one in three adults worldwide has raised blood pressure – the cause of around half of all deaths from stroke and heart disease – and the condition affects almost half the adult population in some countries in Africa…

Why does one person become anorexic and another obese? A study recently published by a University of Colorado School of Medicine researcher shows that reward circuits in the brain are sensitized in anorexic women and desensitized in obese women. The findings also suggest that eating behavior is related to brain dopamine pathways involved in addictions…

Water could change the way we eat. That’s the conclusion of new research by T. Bettina Cornwell of the University of Oregon and Anna R. McAlister of Michigan State University. Their findings appear online this week ahead of regular publication by the journal Appetite. The paper featured separate studies…

That excess weight during pregnancy can lead to overweight children and adolescents has been known for some time, but new research at the Hebrew University of Jerusalem and in the US indicates that excess weight before and during pregnancy can have long-lasting health consequences for the offspring of such mothers even later in life…

Researchers have found that severely obese children respond well to behavioral treatment, but not severely obese adolescents. The study, conducted by Dr. Pernilla Danielsson, Karolinska Institutet, Stockholm, Sweden, was presented at the 19th European Congress on Obesity in Lyon, France…

Individuals who consume egg proteins for breakfast are more likely to feel full during the day than those whose breakfasts contain wheat protein. Results from the study, conducted by Dr. Nikhil Dhurandhar, Pennington Biomedical Research Center, Louisiana, USA, and colleagues were presented at the 19th European Congress on Obesity in Lyon, France…

A new study reveals that waist-to-height ratio (WHtR) is a significantly better predictor of cardiometabolic risk than waist circumference (WC) and body-mass index (BMI). In addition WHtR takes account of differing heights, therefore making it the best proxy to use across all countries. Findings from the study, conducted by Dr…

Lawyers for a French pharmaceutical group suspected in the deaths of at least 500 people argued Monday that a trial against their client should be halted as two separate cases should be rolled into one before the court can proceed.

The Kentucky Supreme Court will hear an appeal from a group of people sickened by the diet-drug fen-phen who say that a $42 million judgment awarded to them from their one-time attorneys should be reinstated.

NANTERRE, France (Reuters) – French drugmaker Servier and its founder went on trial on Monday accused of misleading patients and authorities about a diabetes drug often prescribed for weight loss that officials blame for at least 500 deaths. The case, one of France’s worst health scandals, has put authorities under scrutiny for allowing the sale of Mediator long after the medicine had been pulled in other European countries…

The first French trial has begun over a diabetes drug that was also used to lose weight and is suspected in the deaths of at least 500 people.

NEW YORK, N.Y. – A man murdered during a business meeting in New York City was a top official in a Florida dietary supplement company that has been the target of thousands of consumer complaints.

A man murdered during a business meeting in New York City was a top official in a Florida dietary supplement company that has been the target of thousands of consumer complaints.

FRIDAY, May 11 (HealthDay News) — Obese women often stop getting their periods, but new research suggests weight-loss surgery can help regulate their monthly cycles, while also stemming excessive hair growth and skin problems that often accompany significant weight gain.

THURSDAY, May 10 (HealthDay News) — A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.

THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.

THURSDAY, May 10 (HealthDay News) — A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.

FRIDAY, May 11 (HealthDay News) — Obese women often stop getting their periods, but new research suggests weight-loss surgery can help regulate their monthly cycles, while also stemming excessive hair growth and skin problems that often accompany significant weight gain.

NEW YORK (Reuters) – One night when Lynn McAfee was 5 years old, her psychologically troubled mother left her at the side of a road as punishment for a now forgotten infraction. In the minutes before her mother’s car returned, the terrified girl looked toward the nearby houses on the suburban Philadelphia street and wondered if she should walk over and ask for help…

THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.

Lorcaserin, an investigational obesity drug, was given a positive recommendation by the Endocrinologic and Metabolic Drugs Advisory Committee, which advises the Food and Drug Administration (FDA). The Committee voted 18 to 4 in favor, with one abstention, in advising the FDA whether to approve the medication for obese or overweight individuals…

According to research from Brigham and Women’s Hospital (BWH), the ingredient that gives hot sauce its heat could play a role in the future of weight loss…

Individuals with the longest commutes by car to and from work were the ones least likely to report frequently engaging in moderate to vigorous exercise, and most likely to show risk factors for poorer cardiovascular and metabolic health These were the findings of a new study by Dr Christine M. Hoehner of Washington University in St…

THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.

THURSDAY, May 10 (HealthDay News) — A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.

THURSDAY, May 10 (HealthDay News) — Levels of certain gut bacteria and low protein intake may raise children’s risk of being obese, new research suggests.

18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country’s first new prescription diet drug in over a decade.

THURSDAY, May 10 (HealthDay News) — A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.

THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.

A panel of experts on Thursday urged US regulators to approve what could be the first new anti-obesity drug on the market in more than a decade — Lorcaserin, made by Arena Pharmaceuticals.